Top Markets
#1 Chainbase Chainbase +36.85%
#2 Kyber Network Crystal Kyber Network Crystal +24.77%
#3 B3 (Base) B3 (Base) +23.23%
#4 Liquid Mercury Liquid Mercury +20.42%
#5 Perle Perle +17.02%
#6 Stargate Finance Stargate Finance +15.71%
#7 Block Street Block Street +15.65%
#8 Trusta AI Trusta AI +12.16%
#9 TRIA TRIA +12.03%
#10 PlaysOut PlaysOut +10.67%
Coin of the day
Chainbase Chainbase
Settings
Language
ENGLISH
Currency
USD
Theme
Bristol-Myers Squibb Company Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

BMY
Rank in Stocks #149
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and... Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
Share Price
$59.43
Market Cap
$121.03B
Change (1 day)
0.83%
Change (1 year)
0.90%
Country
US
Trade Bristol-Myers Squibb Company (BMY)

Category

Healthcare
Number of shares outstanding for Bristol-Myers Squibb Company (BMY)
Number of shares outstanding as of December 2025: 2.04B
According to Bristol-Myers Squibb Company latest financial reports and stock price the company's current number of shares outstanding is 2.04B. At the end of December 2024 the company had 2.03B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Bristol-Myers Squibb Company (BMY) from 2000 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 2.04B 0.00%
2025 2.04B 0.69%
2024 2.03B -2.03%
2023 2.07B -2.86%
2022 2.13B -4.10%
2021 2.22B -1.64%
2020 2.26B 32.43%
2019 1.71B 4.41%
2018 1.63B -0.73%
2017 1.65B -1.56%
2016 1.67B 0.24%
2015 1.67B 0.60%
2014 1.66B 0.79%
2013 1.64B -1.56%
2012 1.67B -1.76%
2011 1.70B -0.76%
2010 1.71B -13.22%
2009 1.97B -0.15%
2008 1.98B 0.36%
2007 1.97B 0.51%
2006 1.96B 0.41%
2005 1.95B 0.51%
2004 1.94B 0.26%
2003 1.94B -3.01%
2002 2.00B 2.95%
2001 1.94B -1.27%
2000 1.97B 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 898.00M -56.00%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
 3.10B 51.89%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.43B 18.99%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.78B -12.77%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 1.91B -6.27%
CH